TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
65%
Neutral
25%
Negative
10%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $34 |
62%
upside
| 6 | +3.9% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $16 |
10%
downside
| 4 | – |
–
| 20 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $74 |
1%
downside
| 2 | +44% |
0
%
| 20 Jan ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $62 |
20%
upside
| 2 | +17% |
0
%
| 9 Jan ‘26 5 months ago |
|
|
|
Neutral
Maintained
| $25 |
21%
downside
| 2 | – |
–
| 6 Jan ‘26 5 months ago |
|
|
|
Overweight
Initiated
| $38 |
238%
upside
| 1 | +33% |
0
%
| 19 Dec ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $15 |
26%
upside
| 2 | -17% |
0
%
| 20 Nov ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $47 |
5%
upside
| 1 | +12% |
0
%
| 18 Nov ‘25 7 months ago |
|
|
|
Underweight
Downgraded
| $263 |
9,327%
upside
| 1 | -60% |
0
%
| 18 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $34 |
0%
upside
| 3 | +31% |
0
%
| 14 Nov ‘25 7 months ago |
|
|
|
Underweight
Downgraded
| – | – | 1 | -96% |
0
%
| 16 Sep ‘25 9 months ago |
|